OSSAMA ZORUB

Allopathic & Osteopathic Physicians|Hospitalist MICHIGAN CITY, IN NPI 1891769303

General Payments — all program years on this page

$1,578.98

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 76
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $359.01 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $359.0119

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
PFIZER INC. $112.055
Amgen Inc. $95.126
Lilly USA, LLC $50.713
Acerta Pharma LLC $41.362
Otsuka America Pharmaceutical, Inc. $25.551
ABBVIE INC. $17.551
E.R. Squibb & Sons, L.L.C. $16.671

By program year

Program yearAmountRecords
2018 $168.339
2019 $80.424
2020 $86.873
2021 $145.376
2022 $164.198
2023 $574.7927
2024 $359.0119

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1101485062 E.R. Squibb & Sons, L.L.C. $16.67 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104587472 AstraZeneca Pharmaceuticals LP $18.36 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105717772 AstraZeneca Pharmaceuticals LP $23.00 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106400905 ABBVIE INC. $17.55 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117726507 Amgen Inc. $19.07 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117726509 Amgen Inc. $17.51 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117726511 Amgen Inc. $15.45 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117726513 Amgen Inc. $13.68 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117726515 Amgen Inc. $15.42 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117726517 Amgen Inc. $13.99 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119009861 Otsuka America Pharmaceutical, Inc. $25.55 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130980582 PFIZER INC. $23.15 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131077798 PFIZER INC. $21.68 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131635530 PFIZER INC. $26.02 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131757226 PFIZER INC. $23.95 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132099297 PFIZER INC. $17.25 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135266776 Lilly USA, LLC $13.39 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135303687 Lilly USA, LLC $21.65 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135313714 Lilly USA, LLC $15.67 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.